Medical Director, Oncology Clinical Development (on-site 2–3 days/week in UK—London or Stevenage; Switzerland—Zug; US—Upper Providence, PA or Waltham, MA; or Poland—Warsaw)
Key Responsibilities:
- Collaborate in a complex matrix environment to develop and execute phase 1–3 interventional clinical trials
- Ensure high-quality protocol development aligned with the Clinical Development Plan (efficacy, safety, differentiation, patient value)
- Contribute end-to-end (protocol concept to final study report) to ensure scientific integrity, timely delivery, and alignment with regulatory approvals, reimbursable medicines, and lifecycle management; incorporate global considerations
- Interpret and summarize study results to define safety, efficacy, PK/PD, and patient reported outcomes; assess applicability to the targeted patient population
- Assume medical responsibility for trials, including real-time medical monitoring (eligibility, study design questions, urgent safety questions)
- Oversee medical review of clinical trial data (directly or via delegated review); oversee blinded review of data packages intended for IDMCs
- Review/monitor safety data with the pharmacovigilance group for active studies
- Author clinical study reports and regulatory documents; respond to health authority and ethics committee queries with cross-functional partners
- Collaborate with Principal Investigators on evaluation of clinical publications (abstracts, posters, manuscripts)
- Network to develop long-term partnerships with thought leaders (internal/external)
- Understand biological mechanisms, clinical strategy, and target-based literature
- Serve on the Clinical Matrix Team for one or more assets
- Represent Clinical Development on disease area strategy, integrated evidence, and medical affairs strategy teams
- Participate in Oncology Clinical Development-wide initiatives and workstreams
Basic Qualifications (Required):
- Medical degree with board certification/eligibility or registration qualifications in medical oncology, hematology, hematology/oncology, general surgery, internal medicine, or pathology
- Oncology experience in pharma/biotech, clinical academic medicine, or clinical medical practice
- Experience conducting/participating in clinical trials (investigator initiated, company sponsored, or cooperative group) and subsequent publications
Preferred Qualifications:
- Medical degree with board/registration qualifications in medical oncology, hematology, or pathology
- Board/registration certified or eligible physician with a PhD
- Experience in Lung or Head & Neck Oncology clinical trials (study design, data review/interpretation, overall clinical development)
- Experience with regulatory requirements to support registration; knowledge and adherence to GCP
- Robust knowledge of disease-specific research priorities, public health needs, competitor landscape, clinical practice trends, and treatment guideline evolution
Benefits/Compensation (as stated):
- Annual base salary (US locations listed): $222,750–$371,250; plus annual bonus and eligibility for share-based long-term incentive; benefits include health insurance, retirement, paid holidays/vacation, and paid caregiver/parental and medical leave
- Poland base salary: PLN 455,250–PLN 758,750 gross; statutory benefits per law; may include bonus/awards and other benefits (e.g., private healthcare, additional paid days off, life insurance, pension, fully paid parental leave)
Application Instructions:
- If you require an accommodation or other assistance to apply, contact Recruitment Staff at usrecruitment.adjustments@gsk.com